1
0
0
News
IFRX.N - | Stock Price & Latest News - Reuterswww.reuters.com › markets › companies › IFRX
www.reuters.com
Korinna Pilz: Chief Clinical Development Officer. Jordan Zwick: Chief Strategy Officer. Richard Brudnick: Non-Executive Independent Director. Anthony Gibney ...
InflaRx Announces Positive Data from Second Interim Analysis of ...www.biopharmcatalyst.com › IFRX › news
www.biopharmcatalyst.com
· Korinna Pilz, Chief Clinical Development Officer of InflaRx. "We are also very happy to see the favorable safety profile of vilobelimab ...
InflaRx Conference Call: PANAMO Ph3 Resultswww.inflarx.de › Investors › Events---Presentations
www.inflarx.de
InflaRx Presentation: Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx. Dr. Korinna Pilz, Chief Clinical Development Officer, ...
InflaRx Completes Enrollment of Vilob... | IFRX Stock Newswww.stocktitan.net › News
www.stocktitan.net
· Korinna Pilz, Global Head of Clinical Research and Development of InflaRx, commented: “The full enrollment of our PG study is a significant ...
Netzwerk-Profile
LinkedIn: Korinna Pilz | LinkedIn
Korinna Pilz’ berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Korinna Pilz dabei hilft ...
LinkedIn: Korinna Pilz | LinkedIn
Korinna Pilz' berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Korinna Pilz dabei hilft, interne ...
LinkedIn: Korinna Pilz - Program Director Clinical Research and LinkedIn
上领英，在全球领先职业社交平台查看Korinna Pilz的职业档案。Korinna的职业档案列出了10 个职位。查看Korinna的完整档案，结识职场人脉和查看相似公司的 ...
Interessen
[PPT] Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively ...www.thelancet.com › article › PIIS (22) › ppt
www.thelancet.com
... Korinna Pilz, MD, Prof Renfeng Guo, MD, Prof Diederik van de Beek, MD, Prof Niels C Riedemann, MD Alexander P.J. Vlaar, Martin Witzenrath, Pieter van ...
[PPT] Anti-C5a antibody IFX-1 (vilobelimab) treatment versus The Lancetwww.thelancet.com › article › PIIS (20) › ppt
www.thelancet.com
... Korinna Pilz, MD, Matthijs C Brouwer, PhD, Ren-Feng Guo, MD, Leo Heunks, PhD, Pieter van Paassen, PhD, Niels C Riedemann, PhD, Diederik van de Beek, PhD.
Biberach (77779, Ortenaukreis) Nachrichtenarchiv von bis...
www.stadtscanner.de
Das Seniorenteam der RVG Biberach - Karin Rösler, Alice Pfau, Lieselotte Gutermann, Korinna Pilz und Simone Götz – bewies ebenfalls einen ...
Management & Beteiligungen
InflaRx Jena - Wer-zu-Wemwww.wer-zu-wem.de › firma › inflarx
www.wer-zu-wem.de
Kontakte. Geschäftsführer Prof. Niels C. Riedemann Dr. Thomas Taapken - früher bei Epigenomics Dr. Korinna Pilz. Gruppe/Gesellschafter. Riedemann u.a.. Typ ...
Vorstand - Erbach/Donau - Lions Deutschlanderbach-donau.lions.de › vorstand
erbach-donau.lions.de
Präsidentin. Korinna Pilz ; IPPräsident. Sascha Rode-Kluge ; Sekretär. Heinz Reuscher ; Schatzmeister. Tahsin Ismail-Tsaous ; Mitgliedschaftsbeauftragter. Hans-Karl ...
Business-Profile
Korinna PILZ | Senior Researcher | MD, MSc
www.researchgate.net
Korinna PILZ, Senior Researcher | Cited by 801 | | Read 21 publications | Contact Korinna PILZ
Firmen-Mitarbeiter
References and Publications - Metronomia Clinical Research GmbHwww.metronomia.net › about-us › references-and-p...
www.metronomia.net
... Korinna Pilz, MD, Renfeng Guo, Prof, MD, Diederik van de Beek, Prof, MD ... Korinna Pilz, Matthijs C. Brouwer, Ren- Feng Guo, Leo M. A. Heunks, Matthias H ...
Ausbildung
Korinna Pilz - Biography
www.marketscreener.com
Currently, Korinna Pilz holds the position of Chief Clinical Development Officer at InflaRx NV. Dr. Pilz is also Member of American Society of Clinical Oncology, Member of European Society for Medical...
Bücher
Ghent University Academic Bibliography - UGent Bibliobiblio.ugent.be › publication
biblio.ugent.be
Korinna Pilz, Natalja Strelkowa, Dan Liu and Sylvie Rottey (UGent). (2015) CANCER CHEMOTHERAPY AND PHARMACOLOGY. 76(4). p Contents. Publications ...
Mutationen der mitochondrialen DNA in kolorektalen Karzinomen ...books.google.com › books › about › Mutationen_d...
books.google.com
Korinna Pilz Bibliographic information. Title, Mutationen der mitochondrialen DNA in kolorektalen Karzinomen. Author, Korinna Pilz. Published,
A phase I study of volasertib combined with afatinib, in advanced...
biblio.ugent.be
Machiels, Jean-Pascal, Marc Peeters, Catherine Herremans, Veerle Surmont, Pol Specenier, Marina De Smet, Korinna Pilz, Natalja Strelkowa, ...
Mutationen Der Mitochondrialen DNA in Kolorektalen Karzinomen -...
books.google.de
Korinna Pilz pages. 0 Reviewshttp://books.google.com/books/about/Mutationen_Der_Mitochondrialen_DNA_in_Ko.html?id=etq4tgAACAAJ ...
Dokumente zum Namen
Anti-C5a Antibody (IFX-1) Treatment of Severe COVID-19papers.ssrn.com › sol3 › papers
papers.ssrn.com
· ... Korinna Pilz, Matthijs C. Brouwer, Ren-Feng Guo, Leo Heunks, Pieter van Paassen, Niels. C. Riedemann, Diederik van de Beek :: SSRN. Skip to ...
Open Payments is a public database containing information ...coi.asco.org › Report › ViewAbstractCOI
coi.asco.org
Korinna Pilz. Consulting or Advisory Role - Innate Pharma. Youn H. Kim. Consulting or Advisory Role - Actelion; Celgene; Eisai; Forty Seven; Galderma; Horizon ...
[PDF] Présentation PowerPoint - ER Congressiwww.ercongressi.it › t-cell-slide
www.ercongressi.it
Dr Korinna PILZ. Frederique MORIETTE. Anne TIROUVANZIAM-MARTIN. Manufacturing & Control. Christian BELMANT. Clinical Operations. Christine PAIVA. Robert ZERBIB.
The anti‐C5a antibody vilobelimab efficiently inhibits C5a in patients ...www.scienceopen.com › document
www.scienceopen.com
· . Korinna Pilz: . Matthijs C. Brouwer: ORCID: https://orcid.org m.c. ...
Wissenschaftliche Veröffentlichungen
Lipopolysaccharides and leukotriene B4 induce independently ...www.sciencedirect.com › science › article › pii › pdf
www.sciencedirect.com
Hubertus K611er a,* Walter D~iubener b Korinna Pilz b Mario Siebler a a Department of Neurology, Heinrich-Heine UniL,ersity, Moorenstrafle 5, P.O. Box
Clinical and Translational Science - ScienceGatewww.sciencegate.app › sources
www.sciencegate.app
Korinna Pilz ◽ ... Download Full-text · scholarly journals Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a ...
OPUS 4 | Anti-C5a antibody (vilobelimab) therapy for critically ill ...opus.bibliothek.uni-augsburg.de › index › docId
opus.bibliothek.uni-augsburg.de
· Jorens, Robert Zerbib, Simon Rückinger, Korinna Pilz, Renfeng Guo, Diederik van de Beek, Niels C. Riedemann, Ulrich Jaschinski. Export ...
A new, simple, bioassay for human IFN-y - ScienceDirect.comwww.sciencedirect.com › science › article › pii › pdf
www.sciencedirect.com
Walter D~iubener *, Nicole Wanagat, Korinna Pilz, Sarnira Seghrouchni,. Hans Georg Fischer, Ulrich Hadding. Institut fiir Med. Mikrobiologie und Virologie ...
Veröffentlichungen allgemein
Phase I trial of volasertib, a Polo-like kinase inhibitor SpringerLinklink.springer.com › article
link.springer.com
· Korinna Pilz,; Dan Liu & … Patrick Schöffski. Show authors ... Gerd Munzert, Korinna Pilz & Dan Liu. Authors. Ahmad Awada. View author ...
A phase I study of volasertib combined with afatinib, in advanced...
link.springer.com
Korinna Pilz was an employee of Boehringer Ingelheim at the time of execution and analysis of the study. All remaining authors have declared ...
Phase I trial of volasertib, a Polo-like kinase inhibitor, plus...
link.springer.com
... Thierry Berghmans (1); Marie-Anne Meeus (3); Jessica Cescutti (4); Gerd Munzert (5); Korinna Pilz (5); Dan Liu (5); Patrick Schöffski (2).
Korinna Pilz - Deutsche Digitale Bibliothek
www.deutsche-digitale-bibliothek.de
WebFormulieren Sie Ihre Suchanfrage genauer. Sie können festlegen, ob einer der Suchbegriffe, eine genaue Wortfolge oder alle Suchbegriffe in den Ergebnissen …
Artikel & Meinungen
InflaRx Announces Decision to Enter Phase III Development of IFX www.cnn.com › newsfeeds › globenewswire
www.cnn.com
· Korinna Pilz, Global Head of Clinical R&D at InflaRx, noted: “Data from the initial exploratory Phase II part of the study in patients with ...
InflaRx Aktie • User Camper69, :35 Uhrwww.boersennews.de › community › diskussion › inflarx-n-v-eo-0-12
www.boersennews.de
· Aus dem Nachbarforum - Korinna Pilz ist immer noch mit von der Partie - https://www.northdata.de/ClinDevConsult+GmbH,+Dornstadt/Amtsgericht+ ...
[PDF] Hinweise, Termine 5 Wissenswertes aus dem B - Stadt Erbachwww.erbach-donau.de › cms › Erbacher_Nachrichten_2015_KW_50
www.erbach-donau.de
· Korinna Pilz. Präsidentin des Lions Clubs Erbach/Donau. Bildunterschrift: Blick in den weihnachtlichen Stadel. Photo: Lions Club Erbach, mit ...
Sonstiges
InflaRx Reports Second Quarter Financial & Operating Resultsfinance.yahoo.com › news › inflarx-reports-second-...
finance.yahoo.com
· Korinna Pilz to Chief Clinical Development Officer. Korinna has an impressive background with more than 20 years of drug development experience ...
Dr. Korinna Pilz M.D., M.Sc. Net Worth (2023) | wallminejp.wallmine.com › xetra › officer › dr-korinna-pilz-...
jp.wallmine.com
Dr. Korinna Pilz M.D., M.Sc. is the Chief Clinical Devel. Officer at InflaRx N.V..
Korinna Pilz email address & phone number | InflaRx N.V. Chief ...rocketreach.co › korinna-pilz-email_
rocketreach.co
Get Korinna Pilz's email address () and phone number () at RocketReach. Get 5 free searches.
Korinna Pilz | CiNii Research - 国立情報学研究所cir.nii.ac.jp › crid
cir.nii.ac.jp
Korinna Pilz · 関連論文 · 関連研究データ · 関連図書・雑誌 · 関連博士論文 · 関連プロジェクト · 関連その他成果物 · 詳細情報 · 外部サイトでさがす.
Korinna Pilz · Anschrift · Gesellschaftsvertrag · Firmensitz: Dornstadtwww.northdata.de › ... › Registerbekanntmachungen › Veränderungen
www.northdata.de
Die Visualisierungen zu "ClinDevConsult GmbH - Geschäftsführer: Korinna Pilz · Anschrift · Gesellschaftsvertrag · Firmensitz: Dornstadt" werden von North ...
Korinna Pilz, Dornstadt - North Datawww.northdata.de › Personen › Dornstadt
www.northdata.de
Firmenbekanntmachungen und Netzwerk zu Korinna Pilz, Dornstadt: ClinDevConsult GmbH, vormals: InflaRx GmbH.
SEC.govwww.sec.gov › edgar › data › brhc _ex99-1
www.sec.gov
Korinna Pilz, Chief Clinical Development Officer. “We have incorporated the FDA's feedback into the trial design and can now move forward with initiating ...
A Randomized, Open-Label Phase II Trial of Volasertib as PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
... Korinna Pilz , Quincy Chu. Affiliations. 1 Juravinski Cancer Centre, Hamilton, Ontario, Canada. Electronic address: . 2 Princess Margaret ...
Anti-C5a antibody (vilobelimab) therapy Vrije Universiteit Brusselresearchportal.vub.be › publications › fingerprints
researchportal.vub.be
Robert Zerbib, Simon Rückinger, Korinna Pilz, Renfeng Guo, Diederik van de Beek, Niels C Riedemann. Supporting clinical sciences · Intensive Care. Research ...
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively ...www.x-mol.com › paper
www.x-mol.com
... Korinna Pilz 16 , Renfeng Guo 18 , Diederik van de Beek 5 , Niels C Riedemann 16 ,. Affiliation. Department of Intensive Care, Amsterdam UMC, Amsterdam ...
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best ...europepmc.org › article › pmc
europepmc.org
... Korinna Pilz. jInflaRx, Jena, Germany. Find articles by Korinna Pilz. Matthijs C Brouwer. bDepartment of Neurology, Amsterdam Neuroscience, University of ...
Complement inhibition in severe COVID-19 – Blocking C5a seems ...ouci.dntb.gov.ua › works
ouci.dntb.gov.ua
... Korinna Pilz, Renfeng Guo, Diederik van de Beek, Niels C Riedemann, Alexander P.J. Vlaar, Martin Witzenrath, Pieter van Paassen, Leo M.A. Heunks, Bruno ...
INFLARX N.V. Management | Profil | Unternehmen - boerse.dewww.boerse.de › unternehmensprofil › INFLARX-NV-Aktie
www.boerse.de
Korinna Pilz, Mitglied. Jordan Zwick, Mitglied. Dr. Thomas Taapken, Mitglied. Renfeng Guo, Mitglied. InflaRx N.V. Aufsichtsrat. Nicolas Fulpius. Tony Gibney.
Induction of toxoplasmostasis in a human glioblastoma by interferon ywww.jni-journal.com › article › pdf
www.jni-journal.com
Walter Daubener a Korinna Pilz a Samira Seghrouchni Zennati a, Thomas Bilzer b,. Hans-Georg Fischer a and Ulrich Hadding b a Institut fiir Medische ...
InflaRx Announces Positive Data from Second Interim Nasdaqwww.nasdaq.com › press-release › inflarx-announce...
www.nasdaq.com
· Korinna Pilz, Chief Clinical Development Officer of InflaRx. “We are also very happy to see the favorable safety profile of vilobelimab ...
InflaRx 报告2021 年第二季度财务和经营业绩 - 雪球xueqiu.com › ...
xueqiu.com
“我很高兴地宣布 Korinna Pilz 博士晋升为首席临床开发官。Korinna 拥有令人印象深刻的背景，在生物技术和大型制药领域拥有 20 多年的药物开发经验。在过去几年中 ...
Martin Witzenrath - ESCMID eLibraryelibrary.escmid.org › ...
elibrary.escmid.org
... Korinna Pilz, Renfeng Guo, Diederik Van De Beek, Niels Riedemann. Event: ECCMID 2023, Copenhagen, Denmark. Session: 12e. Drug development and treatment ...
Nintedanib | Citations | Top Authors | Related Topicstypeset.io › Topic Directory › Nintedanib
typeset.io
... Korinna Pilz 3, L. Clementi 3, Dan Liu 3, Patricia Glomb 3, Tommaso De Pas 2 - Show less +4 more • Institutions (3). Marche Polytechnic University
Phase I study of volasertib (BI 6727) combined with afatinib (BIBW ...ascopubs.org › abs › jco _suppl.2521
ascopubs.org
· , Korinna Pilz. x. Korinna Pilz. Search for articles by this author. , Marina De Smet. x. Marina De Smet. Search for articles by this author.
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients ...researchinformation.amsterdamumc.org › publications
researchinformation.amsterdamumc.org
... Korinna Pilz, Matthijs C Brouwer, Ren-Feng Guo, Leo M A Heunks, Matthias H Busch, Pieter van Paassen, Niels C Riedemann, Diederik van de Beek · Intensive Care ...
Verwandte Suchanfragen zu Korinna Pilz
| Simon Rückinger Martin Witzenrath Thomas Taapken |
Person "Pilz" (12) Vorname "Korinna" (501) Name "Pilz" (1367) |
sortiert nach Relevanz / Datum